BSE Live
Jan 01, 16:01Prev. Close
376.25
Open Price
379.75
Bid Price (Qty.)
378.00 (50)
Offer Price (Qty.)
378.00 (150)
NSE Live
Jan 01, 15:58Prev. Close
376.30
Open Price
379.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
377.65 (727)
| Balance Sheet of Panacea Biotec (in Rs. Cr.) | Mar 05 | Mar 04 | |
| 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | |||
| SHAREHOLDER'S FUNDS | |||
| Equity Share Capital | 5.72 | 5.72 | |
| Total Share Capital | 96.15 | 101.50 | |
| Reserves and Surplus | 119.24 | 103.90 | |
| Total Reserves and Surplus | 119.24 | 103.90 | |
| Total Shareholders Funds | 215.39 | 205.40 | |
| NON-CURRENT LIABILITIES | |||
| Long Term Borrowings | 50.81 | 64.72 | |
| Deferred Tax Liabilities [Net] | 14.83 | 9.16 | |
| Other Long Term Liabilities | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 65.64 | 73.88 | |
| CURRENT LIABILITIES | |||
| Short Term Borrowings | 110.23 | 102.98 | |
| Trade Payables | 53.73 | 25.04 | |
| Other Current Liabilities | 4.65 | 4.09 | |
| Short Term Provisions | 24.21 | 10.40 | |
| Total Current Liabilities | 192.83 | 142.51 | |
| Total Capital And Liabilities | 473.85 | 421.79 | |
| ASSETS | |||
| NON-CURRENT ASSETS | |||
| Tangible Assets | 101.86 | 90.01 | |
| Intangible Assets | 7.28 | 6.63 | |
| Capital Work-In-Progress | 28.54 | 8.81 | |
| Other Assets | 0.00 | 0.00 | |
| Fixed Assets | 137.68 | 105.45 | |
| Non-Current Investments | 6.14 | 3.91 | |
| Deferred Tax Assets [Net] | 1.32 | 1.69 | |
| Long Term Loans And Advances | 0.00 | 0.00 | |
| Other Non-Current Assets | 1.45 | 1.93 | |
| Total Non-Current Assets | 146.59 | 112.98 | |
| CURRENT ASSETS | |||
| Current Investments | 0.00 | 0.00 | |
| Inventories | 191.01 | 176.39 | |
| Trade Receivables | 78.73 | 49.21 | |
| Cash And Cash Equivalents | 7.51 | 63.50 | |
| Short Term Loans And Advances | 50.03 | 19.71 | |
| OtherCurrentAssets | 0.00 | 0.00 | |
| Total Current Assets | 327.27 | 308.81 | |
| Total Assets | 473.85 | 421.79 | |
| OTHER ADDITIONAL INFORMATION | |||
| CONTINGENT LIABILITIES, COMMITMENTS | |||
| Contingent Liabilities | 18.55 | 3.51 | |
| CIF VALUE OF IMPORTS | |||
| Raw Materials | 143.68 | 110.77 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | |
| Capital Goods | 4.38 | 2.07 | |
| EXPENDITURE IN FOREIGN EXCHANGE | |||
| Expenditure In Foreign Currency | 7.33 | 9.84 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | |||
| Dividend Remittance In Foreign Currency | 0.57 | 0.57 | |
| EARNINGS IN FOREIGN EXCHANGE | |||
| FOB Value Of Goods | 13.67 | 14.24 | |
| Other Earnings | 0.74 | 0.64 | |
| BONUS DETAILS | |||
| Bonus Equity Share Capital | 1.81 | 1.81 | |
| NON-CURRENT INVESTMENTS | |||
| Non-Current Investments Quoted Market Value | -- | 0.18 | |
| Non-Current Investments Unquoted Book Value | 6.14 | 3.84 | |
| CURRENT INVESTMENTS | |||
| Current Investments Quoted Market Value | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- |
26.12.2025
16.12.2025
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y